PBL InterferonSource Introduces Multiplex ELISA Arrays

PBL InterferonSource introduces the Quansys Q-Plex Cytokine Multiplex Enzyme-Linked Immunosorbent Assay (ELISA) arrays – high-throughput interferon detection kits that can save time and provide key information for drug discovery and clinical research efforts in the treatment of infectious diseases and autoimmunity.

The kits combine various cytokine antibodies within multiplex arrays to give researchers a better understanding of the simultaneous relationship between multiple cytokines. Examination of these relationships reveals information that can help predict clinical outcomes based on several cytokine and growth factor biomarkers including:

• Assessment of cytokine profiles at various points throughout the course of disease;

• Correlation of cytokine profile alterations with patient responses to therapies;

• Determination of drugs’ off-target effects.

The quantitative ELISA-based tests contain up to 16 distinct capture antibodies in each well of a 96-well plate. Each spot is well defined and represents a distinct antibody population. Up to 84 different samples can be assayed for all 16 unique cytokines in less than 2.5 hours.

PBL InterferonSource,

www.interferonsource.com